Calpain 3 gene mutations: genetic and clinico-pathologic findings in limb-girdle muscular dystrophy
- 1 September 2001
- journal article
- Published by Elsevier in Neuromuscular Disorders
- Vol. 11 (6-7) , 547-555
- https://doi.org/10.1016/s0960-8966(01)00197-3
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophyNature Genetics, 1998
- A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2BNature Genetics, 1998
- Autosomal recessive limbgirdle muscular dystrophy, LGMD2F, is caused by a mutation in the δ–sarcoglycan geneNature Genetics, 1996
- Mutations in the Dystrophin-Associated Protein γ-Sarcoglycan in Chromosome 13 Muscular DystrophyScience, 1995
- β–sarcoglycan: characterization and role in limb–girdle muscular dystrophy linked to 4q12Nature Genetics, 1995
- β–sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complexNature Genetics, 1995
- 30th and 31st ENMC international workshops, Naarden, The Netherlands, Held 6–8 January 1995Neuromuscular Disorders, 1995
- Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2ACell, 1995
- Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophyCell, 1994
- ON THE CLASSIFICATION, NATURAL HISTORY AND TREATMENT OF THE MYOPATHIESBrain, 1954